Syracuse gets $7.6 million lab to study deadly infections, head off next pandemic
Syracuse gets $7.6 million lab to study deadly infections, head off next pandemic Updated Mar 12, 2021; Facebook Share Syracuse, N.Y. – A $7.6 million lab designed to let researchers safely work with potentially deadly infections such as Covid-19, Lyme disease and West Nile virus opened today at SUNY Upstate Medical University. It is the first level-3 biosafety lab at Upstate and the only one in the SUNY system statewide. Researchers will use the facility, known as the Vector Biocontainment Lab, to develop an anti-tick vaccine and other treatments to fight diseases spread by mosquitoes an...
Source: syracuse.com